DuPont de Nemours (NYSE: DD) insider files Form 144 to sell shares

Rhea-AI Filing Summary

DuPont de Nemours, Inc. insider plans to sell common stock under Rule 144. A notice was filed to sell 72,958 shares of common stock through Merrill Lynch on the NYSE, with an aggregate market value of $2,993,940.97. The filing notes that 418,975,324 shares of this class are outstanding.

The shares to be sold were acquired mainly through employee stock option exercises and vesting of restricted stock units and performance share awards between 2020 and 2025 under the issuer’s equity compensation plans. During the past three months, the seller previously disposed of 43,208 common shares for gross proceeds of $3,334,079.77. By signing, the seller represents they are not aware of any undisclosed material adverse information about DuPont’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	72958	2993940.97	418975324	12/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/09/2025	Exercise of employee stock options	DuPont de Nemours, Inc.			42669	12/09/2025	Broker assisted cashless exercise
Common Stock	02/14/2020	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			1649	02/14/2020	Granted as part of issuer equity compensation plan
Common Stock	02/14/2021	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			1830	02/14/2021	Granted as part of issuer equity compensation plan
Common Stock	02/19/2021	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			527	02/19/2021	Granted as part of issuer equity compensation plan
Common Stock	03/02/2022	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			348	03/02/2022	Granted as part of issuer equity compensation plan
Common Stock	02/13/2023	Vesting of performance share award	DuPont de Nemours, Inc.			4068	02/13/2023	Granted as part of issuer equity compensation plan
Common Stock	02/19/2023	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			547	02/19/2023	Granted as part of issuer equity compensation plan
Common Stock	02/23/2023	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			531	02/23/2023	Granted as part of issuer equity compensation plan
Common Stock	03/02/2023	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			456	03/02/2023	Granted as part of issuer equity compensation plan
Common Stock	02/14/2024	Vesting of performance share award	DuPont de Nemours, Inc.			4968	02/14/2024	Granted as part of issuer equity compensation plan
Common Stock	02/23/2024	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			542	02/23/2024	Granted as part of issuer equity compensation plan
Common Stock	03/02/2024	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			468	03/02/2024	Granted as part of issuer equity compensation plan
Common Stock	03/15/2024	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			1	03/15/2024	Granted as part of issuer equity compensation plan
Common Stock	02/15/2025	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			1083	02/15/2025	Granted as part of issuer equity compensation plan
Common Stock	02/20/2025	Vesting of performance share award	DuPont de Nemours, Inc.			4221	02/20/2025	Granted as part of issuer equity compensation plan
Common Stock	02/23/2025	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			554	02/23/2025	Granted as part of issuer equity compensation plan
Common Stock	05/04/2025	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			994	05/04/2025	Granted as part of issuer equity compensation plan
Common Stock	11/01/2025	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			7502	11/01/2025	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Steven Larrabee 974 CENTRE ROAD BUILDING 730 WILMINGTON DE 19805	Common Stock	09/15/2025	43208	3334079.77

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many DuPont (DD) shares are covered by this Form 144 notice?

The notice covers the proposed sale of 72,958 shares of DuPont de Nemours, Inc. common stock.

What is the market value of the DuPont (DD) shares to be sold?

The aggregate market value of the shares covered by the notice is $2,993,940.97.

On which exchange will the DuPont (DD) shares be sold and through which broker?

The common shares are indicated for sale on the NYSE through broker Merrill Lynch, located at 225 Liberty St, Floor 37, New York, NY 10281.

How were the DuPont (DD) shares in this Form 144 acquired?

The shares were acquired through exercise of employee stock options and the vesting of restricted stock units and performance share awards granted by DuPont de Nemours, Inc. under its equity compensation plans.

How many DuPont (DD) shares has the seller disposed of in the past three months?

During the past three months, the seller disposed of 43,208 common shares of DuPont, generating gross proceeds of $3,334,079.77.

How many DuPont (DD) common shares are outstanding according to this notice?

The notice states that there are 418,975,324 shares of DuPont common stock outstanding.

What representation does the seller make in this DuPont (DD) Form 144 filing?

By signing, the seller represents that they do not know of any material adverse information about DuPont’s current or prospective operations that has not been publicly disclosed.